An existing literature agrees that drug innovation has a significant average effect on extending longevity and improving quality of life. Recognizing the life-saving benefits from the development of new drugs, one of the key decisions faced by the authorities is how to bolster pharmaceutical innovation, and how to bear in mind the potential effects on drug innovation of policies that affect market size, such as policies towards intellectual property rights, procurement mechanisms and competition policy.
Business and Europe: The Reform Agenda
Date
10 Sep 2014 19:00
Section
Innovation & Enterprise
Event Location
Brussels
Event Description
Pro Europa (www.proeuropa.org.uk) invites for a conference with Simon Walker, the Director-General of the Institute of Directors (IoD) “Business and Europe: the reform agenda”
Date and time: Wednesday, 10th September 2014 at 7.00 pm
The honorary guest: Simon Walker, Director-General of the Institute of Directors (IoD), former Chief Executive of the BVCA, Director of Corporate Communications and Marketing at Reuters, and Communications Secretary to HM The Queen at Buckingham Palace.
Venue: the British Chamber of Commerce, boulevard Bischoffsheim 11, 1000, Brussels.
Number of places is limited and the priority is given to members of Pro Europa.
RSVP: office@proeuropa.org.uk
Events of the week
Jobs
FoodUnfolded
Climate Action Network Europe (CAN Europe)
CLERENS
European Federation of Education Employers
European Cyclists’ Federation
SOCIEUX +
Hanbury Strategy
EURACTIV News
- UK backs NI deal reforms, but former PMs Johnson and Truss lead rebellion
- EU Commission pitches legislation to boost repair services
- EU institutions, member states in competition over cyber intelligence
- France looking to liberal Netherlands in push for nuclear revival
- EU pharma reform delayed again due to Commission’s busy agenda